HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atanas Kamburov Selected Research

BAY-8002

11/2018Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atanas Kamburov Research Topics

Disease

9Neoplasms (Cancer)
12/2019 - 01/2013
2Microsatellite Instability
12/2019 - 12/2019
1Hodgkin Disease (Hodgkin's Disease)
12/2019
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2018
1Carcinogenesis
12/2011

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
08/2017 - 01/2013
2ApolipoproteinsIBA
12/2019 - 12/2019
2Peptides (Polypeptides)IBA
12/2019 - 12/2019
2Messenger RNA (mRNA)IBA
12/2019 - 12/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2016
1Programmed Cell Death 1 ReceptorIBA
12/2019
1Cytidine DeaminaseIBA
12/2019
1Phosphates (Orthophosphate)IBA
12/2019
1CytosineIBA
12/2019
1CarcinogensIBA
12/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1BAY-8002IBA
11/2018
1Monocarboxylic Acid TransportersIBA
11/2018
1Complement System Proteins (Complement)IBA
01/2018
1Oncogene Proteins (Oncogene Protein)IBA
10/2015
1Mitogen-Activated Protein KinasesIBA
12/2011

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2019
1Therapeutics
01/2019